Gitlab Inc.
$8.31B- Market cap
- $8.44B
- Debt
- +$106.45M
- Cash
- −$229.58M
Capital structure 99% equity / 1% debt · EV / Revenue 8.70x
Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2026 · Mkt capMarket cap $8.44B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 ·
Decision snapshot: GTLB stock price at premium vs BHC $49.83 current versus $1.37 implied using P/S multiple.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at BHC's multiple
Implied fair value · at GTLB's multiple
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: GTLB FY 2026 (ended Jan 31, 2026) · BHC FY 2025 (ended Dec 31, 2025). Fiscal years are not aligned.
Trendline
Six fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 99% equity / 1% debt · EV / Revenue 8.70x
Capital structure 10% equity / 90% debt · EV / Revenue 2.16x · EV / EBITDA 9.16x
BHC carries the larger enterprise value at $22.19B against $8.31B; BHC trades on the lower EV / Revenue multiple (2.16x vs 8.70x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
GITLAB INC. · implied price per share
At least 3 of the last 5 annual free-cash-flow observations must be positive.
Bausch Health Companies Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
0.11x
-37.98x
Net debt / EBITDA
Leverage against operating earnings
3.61x
8.15x
Cash and equivalents
Liquid reserves on the balance sheet
$229.58M
$1.31B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Atlassian Corp
GTLB vs TEAM
Cloudflare, Inc.
GTLB vs NET
PagerDuty, Inc.
GTLB vs PD
ServiceNow, Inc.
GTLB vs NOW
Dynatrace, Inc.
GTLB vs DT
AbbVie Inc.
GTLB vs ABBV
Organon & Co.
GTLB vs OGN
TEVA PHARMACEUTICAL INDUSTRIES LTD
GTLB vs TEVA
SUPERNUS PHARMACEUTICALS, INC.
GTLB vs SUPN
ANI PHARMACEUTICALS INC
GTLB vs ANIP
$106.45M
$21.04B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.